From neurotoxicity to neuroplasticity: a lifesaving drug that must be used with respect
33:15
Ketamine vs. ECT: implications for clinical practice, policy and future research
31:13
Addiction potential of ketamine enantiomers and metabolites, and of esmethadone
33:06
R-Ketamine for Treatment Resistant Depression
30:16
Opioid use reduces placebo response independently of pain in a ketamine depression trial
30:07
Long-term safety and durable efficacy of esketamine in TRD and ESCAPE-TRD
29:53
Prucalopride (5HT4a agonist) plus ketamine: additive effects on stress
33:53
Where are we with the ketamine-opioid story?
29:56